TP53 and lung adenocarcinoma: A study used two types of lung adenocarcinoma cells: A549 (wild type TP53) and SK-MES-1 (TP53 deficient) to evaluate the effects of budesonide and fenofibrate, alone and in combination, which showed differential effects on the growth of lung cancer cells, in a PPAR-α-independent fashion.